🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A

RecruitingPhase 2Ages 20 Years - 45 YearsAllKarolinska Institutet
NCT05720065 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to investigate the effect of botulinum toxin on neurons' plasticity in the masseter muscle in humans with and without painful myogenous temporomandibular disorders (TMDM). The main questions it aims to answer are: * does treatment with botulinum toxin alter gene expressions, epigenetic signatures, and cells plasticity in the masseter muscles of TMDM patients? * do any such changes differ between patients with local and regional TMDM? * does treatment with botulinum toxin influence pain characteristics (intensity, frequency, and sensibility) and other variables in patients with TMDM and are there correlations between significantly changed expression of biomarkers and other variables? Participants will be examined with a questionnaire, clinical examination (including quantitative sensory testing; QST), and microbiopsy sampling from one of the masseter (

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * a diagnosis of TMDM myalgia or myofascial pain according to the DC/TMD criteria * females with adequate contraceptives and a negative pregnancy test * pain upon digital palpation of at least one of the masseter muscle * a characteristic pain intensity of \> 40/100 * a negative pregnancy test at the day of treatment Exclusion Criteria: * difficulties understanding the Swedish language * systemic inflammatory connective tissue diseases * widespread pain * neuromuscular disorders * diagnosed or severe psychiatric disease * neuropathic pain * pain of dental origin * history of trauma to the face, head or neck * pregnancy or nursing * known allergy to botulinum toxin or antibiotics * use of muscle relaxants, antidepressant, neuropsychiatric, anticoagulant drugs, or aminoglycoside antibiotics * previous treatment with botulinum toxin during the last 12 months * use of analgesic or anti-inflammatory medication during the 48 hours preceding biopsy * skin infection over injection/biopsy site
💊

What it tests

  • Botulinum toxin type A
  • Isotonic saline 0,9%
📍

Where

1 site
Department of Dental Medicine, Karolinska Institutet
Huddinge, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy